Sign inJoin waitlistJoin the waitlist

Michael Deel

Associate Professor of Clinical-Affiliate · University of Cincinnati Medical Center Inc.

Credentials: · · ·

History

University of Cincinnati Medical Center Inc.
Present
Cincinnati Children's Hospital Medical Center
Present
Duke University Hospital
Present

Pediatric Hematology Oncology
Duke University Hospital
2013–2016
Pediatrics
University of Louisville
2011–2013
Marshall University - Joan C. Edwards School of Medicine
2006–2010

Research

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
Review · Frontiers in Oncology · 2015 · First of 4 authors · 61 citations
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
Review · Journal of Clinical Medicine · 2021 · 27 citations
The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Clinical Cancer Research · 2018 · First of 10 authors · 23 citations

Corinne Linardic
6 papers · 1 as a resident
Rex Bentley
3 papers
Javed Khan
2 papers
Katia Genadry
2 papers · 2 as a resident
Ashley Hinson
1 paper
Brian Turpin
1 paper
Bruce Pawel
1 paper
CK
Charles Keller
1 paper
Christine Heske
1 paper
David Noyd
1 paper · 1 as a fellow
Douglas Harrison
1 paper
Douglas Hawkins
1 paper

Clinical trials

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Principal investigator · Active not recruiting · Phase 1
Valent Technologies, LLC
2021–2026
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Site PI · Recruiting · Phase 1
Inhibrx Biosciences, Inc
2018–2029